Oxford Immunotec Global PLC nets $68.8mm via IPO
UK-based Oxford Immunotec Global PLC (develops diagnostics that measure effector T-cell response to certain antigens) netted $68.8mm in its initial public offering of 6.16mm ordinary shares (including the overallotment) at $12 on Nasdaq. The company originally thought it would sell the shares between $13 and $15.
- In Vitro Diagnostics
- Laboratory Testing Services
In Vitro Diagnostics
- Chemistry, Immunoassay
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.